Weiss Multi-Strategy Advisers’s Precision BioSciences DTIL Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,580	Closed	-$39K	–	146
2023 Q4	$39K	Hold	3,580	–	–	﹤0.01%	523
2023 Q3	$37K	Hold	3,580	–	–	﹤0.01%	527
2023 Q2	$56K	Hold	3,580	–	–	﹤0.01%	613
2023 Q1	$81K	Buy	3,580 +247	+7%	+$8.14K	﹤0.01%	596
2022 Q4	$119K	Hold	3,333	–	–	﹤0.01%	561
2022 Q3	$130K	Buy	+3,333	New	+$158K	﹤0.01%	632
2022 Q1	–	Sell	-3,333	Closed	-$740K	–	689
2021 Q4	$740K	Buy	+3,333	New	+$931K	0.02%	512
2021 Q1	–	Sell	-10,917	Closed	-$2.73M	–	734
2020 Q4	$2.73M	Sell	10,917 -959	-8%	-$235K	0.05%	364
2020 Q3	$2.19M	Sell	11,876 -3,624	-23%	-$721K	0.06%	334
2020 Q2	$3.87M	Buy	15,500 +3,723	+32%	+$815K	0.11%	240
2020 Q1	$2.13M	Buy	11,777 +1,883	+19%	+$493K	0.08%	245
2019 Q4	$4.12M	Buy	9,894 +7,227	+271%	+$2.27M	0.07%	336
2019 Q3	$671K	Buy	+2,667	New	+$868K	0.01%	471
2019 Q2	–	Sell	-3,272	Closed	-$1.76M	–	539
2019 Q1	$1.76M	Buy	+3,272	New	+$1.74M	0.04%	344

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Weiss Multi-Strategy Advisers's DTIL Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 3,580 shares — an estimated $39K sold.

Weiss Multi-Strategy Advisers first reported a position in DTIL in Q1 2019 and held it in 14 quarters. The position peaked at $4.12M in Q4 2019. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 3,580 Precision BioSciences shares in Q1 2024, an estimated $39K.
Weiss Multi-Strategy Advisers first reported a position in Precision BioSciences in Q1 2019 and held it in 14 quarters.
Weiss Multi-Strategy Advisers's Precision BioSciences position peaked at $4.12M in Q4 2019.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.